Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1173313/000121390017000304/f10k2016_americanbrivision.htm
November 2023
November 2023
November 2023
September 2023
August 2023
August 2023
August 2023
August 2023
July 2023
July 2023
Document and Entity Information - USD ($) | 12 Months Ended | ||
---|---|---|---|
Sep. 30, 2016 | Jan. 06, 2017 | Mar. 31, 2016 | |
Document and Entity Information [Abstract] | |||
Entity Registrant Name | American BriVision (Holding) Corp | ||
Entity Central Index Key | 0001173313 | ||
Amendment Flag | false | ||
Current Fiscal Year End Date | --09-30 | ||
Document Type | 10-K | ||
Document Period End Date | Sep. 30, 2016 | ||
Document Fiscal Year Focus | 2016 | ||
Document Fiscal Period Focus | FY | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Filer Category | Smaller Reporting Company | ||
Entity Common Stock, Shares Outstanding | 210,821,647 | ||
Entity Public Float | $ 35,193,896.2 |
Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1173313/000121390017000304/f10k2016_americanbrivision.htm
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by American Brivision.
American Brivision's Definitive Proxy Statement (Form DEF 14A) filed after their 2017 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 10-K Annual Report
Material Contracts, Statements, Certifications & more
American Brivision provided additional information to their SEC Filing as exhibits
Ticker: ABVC
CIK: 1173313
Form Type: 10-K Annual Report
Accession Number: 0001213900-17-000304
Submitted to the SEC: Thu Jan 12 2017 5:26:35 PM EST
Accepted by the SEC: Thu Jan 12 2017
Period: Friday, September 30, 2016
Industry: Pharmaceutical Preparations